Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
J Cell Sci ; 129(10): 2106-19, 2016 05 15.
Artigo em Inglês | MEDLINE | ID: mdl-27068536

RESUMO

The assembly and maintenance of most cilia and flagella rely on intraflagellar transport (IFT). Recent in vitro studies have suggested that, together, the calponin-homology domain within the IFT81 N-terminus and the highly basic N-terminus of IFT74 form a module for IFT of tubulin. By using Chlamydomonas mutants for IFT81 and IFT74, we tested this hypothesis in vivo. Modification of the predicted tubulin-binding residues in IFT81 did not significantly affect basic anterograde IFT and length of steady-state flagella but slowed down flagellar regeneration, a phenotype similar to that seen in a strain that lacks the IFT74 N-terminus. In both mutants, the frequency of tubulin transport by IFT was greatly reduced. A double mutant that combined the modifications to IFT81 and IFT74 was able to form only very short flagella. These results indicate that, together, the IFT81 and IFT74 N-termini are crucial for flagellar assembly, and are likely to function as the main module for IFT of tubulin.


Assuntos
Proteínas de Transporte/genética , Chlamydomonas reinhardtii/genética , Flagelos/genética , Tubulina (Proteína)/genética , Transporte Biológico/genética , Proteínas de Transporte/metabolismo , Chlamydomonas reinhardtii/metabolismo , Cílios/genética , Cílios/metabolismo , Flagelos/metabolismo , Fenótipo , Ligação Proteica , Tubulina (Proteína)/metabolismo
2.
J Cell Biol ; 208(2): 223-37, 2015 Jan 19.
Artigo em Inglês | MEDLINE | ID: mdl-25583998

RESUMO

The assembly of the axoneme, the structural scaffold of cilia and flagella, requires translocation of a vast quantity of tubulin into the growing cilium, but the mechanisms that regulate the targeting, quantity, and timing of tubulin transport are largely unknown. In Chlamydomonas, GFP-tagged α-tubulin enters cilia as an intraflagellar transport (IFT) cargo and by diffusion. IFT-based transport of GFP-tubulin is elevated in growing cilia and IFT trains carry more tubulin. Cells possessing both nongrowing and growing cilia selectively target GFP-tubulin into the latter. The preferential delivery of tubulin boosts the concentration of soluble tubulin in the matrix of growing versus steady-state cilia. Cilia length mutants show abnormal kinetics of tubulin transport. We propose that cells regulate the extent of occupancy of IFT trains by tubulin cargoes. During ciliary growth, IFT concentrates soluble tubulin in cilia and thereby promotes elongation of the axonemal microtubules.


Assuntos
Cílios/fisiologia , Proteínas de Plantas/metabolismo , Tubulina (Proteína)/metabolismo , Chlamydomonas reinhardtii/ultraestrutura , Difusão , Flagelos/metabolismo , Multimerização Proteica , Transporte Proteico , Regulação para Cima
3.
J Infect Dis ; 209(1): 150-62, 2014 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-23945371

RESUMO

The development of treatment protocols with reduced toxicity and equivalent or improved efficacy for Trypanosoma cruzi infection is a priority. We tested the effectiveness of benznidazole (BZ), nifurtimox (NFX), other prospective drugs in intermittent and combined treatment protocols to cure T. cruzi infection initiated with susceptible and drug-resistant parasite strains. A 40-day course of BZ, NFX, or the oxaborale AN4169 cured 100% of mice, whereas posaconazole (POS), and NTLA-1 (a nitro-triazole) cured approximately 90% and 20% of mice, respectively. Reducing the overall dosage of BZ or NFX by using an intermittent (once every 5 days) schedule or combining 5 daily doses of POS with 7 intermittent doses of BZ also provided approximately 100% cure. T. cruzi strains resistant to BZ were also found to be resistant to other drugs (POS), and extending the time of treatment or combining drugs did not increase cure rates with these isolates. Thus, dosing schedules for anti-T. cruzi compounds should be determined empirically, and compounds targeting different pathways may be combined to yield effective therapies with reduced toxicity. This work also suggests that standard treatment protocols using BZ and NFX may be significantly overdosing patients, perhaps contributing to the adverse events.


Assuntos
Doença de Chagas/tratamento farmacológico , Tripanossomicidas/farmacologia , Trypanosoma cruzi/efeitos dos fármacos , Animais , Biomarcadores , Linfócitos T CD8-Positivos/imunologia , Doença de Chagas/imunologia , DNA/análise , Resistência a Medicamentos , Quimioterapia Combinada , Imunofenotipagem , Camundongos , Camundongos Endogâmicos C57BL , Nitroimidazóis/administração & dosagem , Nitroimidazóis/farmacologia , Nitroimidazóis/uso terapêutico , Parasitemia/tratamento farmacológico , Trypanosoma cruzi/genética , Trypanosoma cruzi/isolamento & purificação
4.
Curr Biol ; 23(24): 2463-71, 2013 Dec 16.
Artigo em Inglês | MEDLINE | ID: mdl-24316207

RESUMO

BACKGROUND: During the assembly and maintenance of cilia, precursor proteins need to be transported from the cell body into the organelle. Intraflagellar transport (IFT) is assumed to be the predominant protein transport pathway in cilia, but it remains largely unknown how ciliary proteins use IFT to reach their destination sites in the cilium and whether the amount of cargo transported by IFT is regulated. RESULTS: Single-particle imaging showed that DRC4, a structural protein of the axoneme, moves in association with IFT particles inside Chlamydomonas reinhardtii cilia. IFT is required for DRC4 transport both into and within the cilium. DRC4 cargoes dissociate from IFT trains at the tip as well as at various sites along the length of the cilium. Unloaded DRC4 diffuses before docking at its axonemal assembly site. In growing cilia, DRC4 transport by IFT was strongly increased over the steady-state level, and the frequency decreased linearly with the increasing ciliary length. The frequency of DRC4 transport was similarly elevated in short growth-arrested cilia and remained high even when the amount of DRC4 available in the cell body was reduced. CONCLUSIONS: DRC4 is a bona fide cargo of IFT. Incompletely assembled cilia trigger an increase in the amount of DRC4 cargo transported by IFT particles, and DRC4 transport is downregulated as cilia approach their steady-state length. We propose a model in which ciliary length is controlled by regulating the amount of cargo transported by IFT particles.


Assuntos
Chlamydomonas reinhardtii/metabolismo , Cílios/metabolismo , Modelos Biológicos , Proteínas de Plantas/metabolismo , Axonema/metabolismo , Chlamydomonas reinhardtii/ultraestrutura , Proteínas de Plantas/análise , Proteínas de Plantas/genética , Transporte Proteico/fisiologia
5.
J Cell Biol ; 201(2): 249-61, 2013 Apr 15.
Artigo em Inglês | MEDLINE | ID: mdl-23589493

RESUMO

The BBSome is a complex of seven proteins, including BBS4, that is cycled through cilia by intraflagellar transport (IFT). Previous work has shown that the membrane-associated signaling protein phospholipase D (PLD) accumulates abnormally in cilia of Chlamydomonas reinhardtii bbs mutants. Here we show that PLD is a component of wild-type cilia but is enriched ∼150-fold in bbs4 cilia; this accumulation occurs progressively over time and results in altered ciliary lipid composition. When wild-type BBSomes were introduced into bbs cells, PLD was rapidly removed from the mutant cilia, indicating the presence of an efficient BBSome-dependent mechanism for exporting ciliary PLD. This export requires retrograde IFT. Importantly, entry of PLD into cilia is BBSome and IFT independent. Therefore, the BBSome is required only for the export phase of a process that continuously cycles PLD through cilia. Another protein, carbonic anhydrase 6, is initially imported normally into bbs4 cilia but lost with time, suggesting that its loss is a secondary effect of BBSome deficiency.


Assuntos
Chlamydomonas reinhardtii/citologia , Chlamydomonas reinhardtii/enzimologia , Cílios/enzimologia , Endocitose , Complexos Multiproteicos/metabolismo , Fosfolipase D/metabolismo , Transdução de Sinais , Fusão Celular , Chlamydomonas reinhardtii/metabolismo , Diglicerídeos/metabolismo , Flagelos/metabolismo , Metabolismo dos Lipídeos , Mutação/genética , Proteínas de Plantas/metabolismo , Transporte Proteico , Fatores de Tempo
6.
Infect Immun ; 79(8): 3397-406, 2011 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-21628516

RESUMO

Trypanosoma cruzi infects millions of people in Latin America and often leads to the development of Chagas disease. T. cruzi infection can be acquired at or near the bite site of the triatomine vector, but per os infection is also a well-documented mode of transmission, as evidenced by recent microepidemics of acute Chagas disease attributed to the consumption of parasite-contaminated foods and liquids. It would also be convenient to deliver vaccines for T. cruzi by the oral route, particularly live parasite vaccines intended for the immunization of reservoir hosts. For these reasons, we were interested in better understanding immunity to T. cruzi following oral infection or oral vaccination, knowing that the route of infection and site of antigen encounter can have substantial effects on the ensuing immune response. Here, we show that the route of infection does not alter the ability of T. cruzi to establish infection in muscle tissue nor does it impair the generation of a robust CD8(+) T cell response. Importantly, oral vaccination with attenuated parasites provides protection against wild-type (WT) T. cruzi challenge. These results strongly support the development of whole-organism-based vaccines targeting reservoir species as a means to alleviate the burden of Chagas disease in affected regions.


Assuntos
Linfócitos T CD8-Positivos/imunologia , Doença de Chagas/prevenção & controle , Proteção Cruzada , Vacinas Protozoárias/imunologia , Trypanosoma cruzi/imunologia , Administração Oral , Animais , Doença de Chagas/imunologia , Camundongos , Camundongos Endogâmicos C57BL , Músculos/parasitologia , Músculos/patologia , Vacinas Protozoárias/administração & dosagem , Trypanosoma cruzi/patogenicidade , Vacinas Atenuadas/administração & dosagem , Vacinas Atenuadas/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA